Additionally, PTPRD/PTPRT mutations were strongly associated with a higher TMB, MSI score, TCR score, higher levels of immune cell infiltration, and enriched immune-related signatures, indicating an enhanced level of anti-tumor immunity in PTPRD/PTPRT mutant cancer patients. This evidence concerns the gene PTPRD and cancer.